Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

Multicenter Early Feasibility Trial of Neonatal, Infant, and Young Child Vascular Stenoses Studying the Renata Minima Stent

MINIMA

Condition: Cardiology
Phase: III
Clinicaltrials.gov ID: NCT05086016

What is the goal of the study?

Early Feasibility Study (EFS) of the Renata Minima Stent for the treatment of vascular narrowing in neonates, infants and young children. There are currently no FDA approved stents for use in this patient population. This is the first stent designed specifically for pediatric patients. It is unique in its design engineering in that, unlike most commercially available stents, it can be implanted at small diameters and later dilated up to a size suitable for adult blood vessels.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Brian Morray
Study Team Member: Jeremy Gillis, Jeremy.Gillis@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.